Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model.

Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model.

Item
http://www.wikidata.org/entity/Q40051004
A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancersInduction of selective blood-tumor barrier permeability and macromolecular transport by a biostable kinin B1 receptor agonist in a glioma rat modelTreatment with bevacizumab plus carboplatin for recurrent malignant glioma.Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme.Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models.The paradoxical effect of bevacizumab in the therapy of malignant gliomas.Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol.A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma.Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model.Advances in malignant glioma drug discovery.Update and developments in the treatment of glioblastoma multiforme - focus on bevacizumab.Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments.Bevacizumab and glioblastoma: scientific review, newly reported updates, and ongoing controversies.New Directions in Anti-Angiogenic Therapy for Glioblastoma.Trastuzumab distribution in an in-vivo and in-vitro model of brain metastases of breast cancer.Correlation of MRI sequences to assess progressive glioblastoma multiforme treated with bevacizumab.
P2860

Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model.

Item
http://www.wikidata.org/entity/Q40051004
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Bevacizumab and carboplatin in ...... umor volume in a glioma model.
@en
type
label
Bevacizumab and carboplatin in ...... umor volume in a glioma model.
@en
prefLabel
Bevacizumab and carboplatin in ...... umor volume in a glioma model.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Bevacizumab and carboplatin in ...... umor volume in a glioma model.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932